Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Genitourinary 1CNS 1

Conditions

Testicular Neoplasms 22Testicular Germ Cell Tumor 15Ovarian Neoplasms 13Teratoma 11Endodermal Sinus Tumor 9Central Nervous System Neoplasms 9Sarcoma 8Carcinoma, Embryonal 8Kidney Neoplasms 7Wilms Tumor 6Seminoma 6Neuroectodermal Tumors, Primitive, Peripheral 6Carcinoma, Renal Cell 6Urinary Bladder Neoplasms 5Osteosarcoma 5Penile Neoplasms 4Ovarian Germ Cell Cancer 4Medulloblastoma 4Rhabdoid Tumor 3Retinoblastoma 3Optic Nerve Glioma 3Neuroblastoma 3Neoplasms 3Astrocytoma 3Urethral Neoplasms 2Teratoma, Testicular 2Sarcoma, Synovial 2Sarcoma, Endometrial Stromal 2Rhabdomyosarcoma 2Pheochromocytoma 2

Interventions

Zoledronic Acid 2Vincristine 2Irinotecan 2Gemcitabine 2Etoposide 2Doxorubicin 2Cyclophosphamide 2saracatinib 1robatumumab 1radium Ra 223 dichloride 1liposomal doxorubicin 1cc-486 1Temozolomide 1Taxes 1Standard of Care 1Radiation 1Quality of Life 1Psychology, Positive 1Practice Guidelines as Topic 1Patient Reported Outcome Measures 1Palliative Care 1Paclitaxel 1Observation 1Molecular Diagnostic Techniques 1Methods 1Lomustine 1Injections 1Immunotherapy 1Ifosfamide 1Genetic Testing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bone Neoplasms × Ifosfamide × Genitourinary × Clear all
NCT00960063 2018-08-27

A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)

Merck Sharp & Dohme LLC

Phase 1 Terminated
4 enrolled 8 charts
CNSGenitourinarySarcoma

Bone Neoplasms, Carcinoma, Renal Cell, Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡